HSBC Holdings
LXRX icon

HSBC Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

HSBC Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,415
Closed -$7.76K – 3149
2025
Q1 		$7.76K Sell
13,415
-87
-0.6% -$55 ﹤0.01% 2994
2024
Q4 		$9.65K Buy
+13,502
New +$16.3K ﹤0.01% 3071
2017
Q1 		– Sell
-10,365
Closed -$144K – 2382
2016
Q4 		$144K Buy
+10,365
New +$166K ﹤0.01% 2585
2015
Q2 		– Sell
-4,712
Closed -$31K – 2198
2015
Q1 		$31K Buy
4,712
+870
+23% +$5.94K ﹤0.01% 2025
2014
Q4 		$24K Buy
+3,842
New +$31K ﹤0.01% 1770

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's LXRX Position: Q2 2025 in Review

HSBC Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 13,415 shares — an estimated $7.76K sold.

HSBC Holdings first reported a position in LXRX in Q4 2014 and held it in 5 quarters. The position peaked at $144K in Q4 2016. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

  • HSBC Holdings reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 13,415 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $7.76K.
  • HSBC Holdings first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • HSBC Holdings's Lexicon Pharmaceuticals position peaked at $144K in Q4 2016.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.